These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 36614282)

  • 21. Noncoding RNAs in age-related cardiovascular diseases.
    Jusic A; Thomas PB; Wettinger SB; Dogan S; Farrugia R; Gaetano C; Tuna BG; Pinet F; Robinson EL; Tual-Chalot S; Stellos K; Devaux Y;
    Ageing Res Rev; 2022 May; 77():101610. PubMed ID: 35338919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly.
    Kuller LH; Lopez OL; Gottdiener JS; Kitzman DW; Becker JT; Chang Y; Newman AB
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement and significance of circulating natriuretic peptides in cardiovascular disease.
    Sagnella GA
    Clin Sci (Lond); 1998 Nov; 95(5):519-29. PubMed ID: 9791037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers in heart failure: the past, current and future.
    Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F
    Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Cardiac Biomarkers in Epidemiology and Risk Outcomes.
    Haller PM; Beer BN; Tonkin AM; Blankenberg S; Neumann JT
    Clin Chem; 2021 Jan; 67(1):96-106. PubMed ID: 33225348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers.
    Lippi G; Cervellin G
    Crit Rev Clin Lab Sci; 2014 Feb; 51(1):13-29. PubMed ID: 24410541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling Population.
    Parikh RH; Seliger SL; Christenson R; Gottdiener JS; Psaty BM; deFilippi CR
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27481133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined measurement of high-sensitivity cardiac troponins and natriuretic peptides: a useful tool for clinicians?
    Perrone MA; Zaninotto M; Masotti S; Musetti V; Padoan A; Prontera C; Plebani M; Passino C; Romeo F; Bernardini S; Clerico A
    J Cardiovasc Med (Hagerstown); 2020 Dec; 21(12):953-963. PubMed ID: 33156589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Biomarkers and Their Potential Role in Heart Failure Treatment Optimisation-An African Perspective.
    Badianyama M; Mpanya D; Adamu U; Sigauke F; Nel S; Tsabedze N
    J Cardiovasc Dev Dis; 2022 Oct; 9(10):. PubMed ID: 36286287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical activity, exercise and cardiac troponins: Clinical implications.
    Aakre KM; Omland T
    Prog Cardiovasc Dis; 2019; 62(2):108-115. PubMed ID: 30797799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomes.
    Yang EY; Khan MA; Graviss EA; Nguyen DT; Bhimaraj A; Nambi V; Hoogeveen RC; Ballantyne CM; Zoghbi WA; Shah DJ
    Sci Rep; 2019 Dec; 9(1):20168. PubMed ID: 31882822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers of cardiovascular damage and dysfunction--an overview.
    Collinson PO; Gaze DC
    Heart Lung Circ; 2007; 16 Suppl 3():S71-82. PubMed ID: 17618829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases.
    Sygitowicz G; Maciejak-Jastrzębska A; Sitkiewicz D
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population.
    Shemisa K; Bhatt A; Cheeran D; Neeland IJ
    Curr Heart Fail Rep; 2017 Aug; 14(4):301-310. PubMed ID: 28639234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers in diagnosing and treatment of acute heart failure.
    Pourafkari L; Tajlil A; Nader ND
    Biomark Med; 2019 Oct; 13(14):1235-1249. PubMed ID: 31580155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combining natriuretic peptides and necrosis markers in determining prognosis in heart failure.
    Fonarow GC; Horwich TB
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S20-8. PubMed ID: 14564225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biomarkers for the diagnosis and management of heart failure: new frontiers].
    Vergaro G; Castiglione V; Aimo A; Prontera C; Musetti V; Masotti S; Giannelli E; Maltinti M; Passino C; Emdin M
    G Ital Cardiol (Rome); 2021 May; 22(5):386-396. PubMed ID: 33960982
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.